紫鑫藥業(002118.SZ):控股股東所持1.32億股司法拍賣股份流拍
格隆匯 9 月 1日丨紫鑫藥業(002118.SZ)公佈,公司於2020年8月4日披露了《關於控股股東部分股份被司法拍賣的提示性公告》,公司控股股東敦化市康平投資有限責任公司(“康平公司”)持有的公司約1.32億股股票(佔公司股份總數的10.33%,佔其持有公司股份總數的28.99%)將於2020年8月31日10時至2020年9月1日10時止(延時除外)在延邊朝鮮族自治州中級人民法院阿里巴巴司法拍賣網絡平台上進行公開拍賣活動(法院賬户名:延邊朝鮮族自治州中級人民法院,法院主頁網址:sf.taobao.com/0433/13)進行公開拍賣。根據“阿里巴巴司法拍賣網絡平台”頁面顯示的拍賣結果,此次拍賣流拍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.